Navigation Links
T-beta-RIII joins the fight against breast cancer

Although the soluble factor TGF-beta has been shown to suppress the growth of tumor cells in the early stages of breast cancer, high levels of TGF-beta during the later stages of the disease are associated with a poor outcome. A study using human breast cancer samples and mice, which appears online on December 7 in advance of publication in the January print issue of the Journal of Clinical Investigation, indicates that changes in expression of one component of the TGF-beta receptor, T-beta-RIII, might provide a mechanism for the distinct effects of TGF-beta at the different stages of breast cancer.

Gerard Blobe and colleagues from Duke University showed that expression of T-beta-RIII by human breast cancer samples markedly decreased or was lost with disease progression. Conversely, in a mouse model of breast cancer, tumor cells engineered to express high levels of T-beta-RIII were less able to invade the breast tissue and to metastasize to other organs than tumor cells not engineered to express this protein. Further analysis revealed that the mechanism behind these protective effects of T-beta-RIII was likely to be T-beta-RIII cleavage at the cell membrane, which releases soluble T-beta-RIII that blocks TGF-beta signaling. As low levels of T-beta-RIII were found to be associated with decreased recurrence-free survival of patients with breast cancer and loss of T-beta-RIII was found to begin before tumors became invasive, the authors suggest that analysis of T-beta-RIII levels might help clinicians decide how aggressively to treat their patients.
'"/>

Source:Journal of Clinical Investigation


Page: 1

Related biology news :

1. New Rotavirus vaccine joins routine infant immunization schedule
2. Learning to fight an adversary that wont stay down
3. Antibiotic might fight HIV-induced neurological problems
4. NYU study reveals how brains immune system fights viral encephalitis
5. Molecular models advance the fight against malaria
6. Molecule that usually protects infection-fighting cells may cause plaque deposits inside arteries
7. Researchers find promising cancer-fighting power of synthetic cell-signaling molecule
8. Agilent Technologies new genome analysis technology set to accelerate Australia fight against mesothelioma
9. Two chemicals boost immune cells ability to fight HIV without gene therapy
10. Experiment station researchers to explore genome of disease-fighting fungus
11. Bacterial genome sheds light on synthesizing cancer-fighting compounds
Post Your Comments:
(Date:12/5/2008)... dose of a commonly used meningitis vaccine may be...ding should allow scarce vaccine resources to be s...frica. , In a study initiated by the Norwegian I... (the research arm of Doctors Without Borders/Mdec...ence and Technology in Uganda, immune responses in...
(Date:12/5/2008)...08 Elsevier, the world,s leading publisher of sci...f the third annual Scopus Young Indian Scientist A... Embassy of Netherlands, presided over the award c... award has been designed to recognize outstanding ... made significant contributions to providing new r...
(Date:12/5/2008)...d that management efforts intended to assist migra...ended consequences for fish populations. Juveniles... the ability to migrate back to their breeding gro...ptations in the wild. , Transportation programs...ove the survival of fish that hatch in rivers but ...
(Date:12/5/2008)...aumann Lab has discovered an important step in the... replenishes the sequences that are lost at chromo...ere published today in the Advance Online Publicat...omising cancer treatment target because its inhibi...dentify small molecules that block telomerase, it ...
Breaking Biology News(10 mins):Elsevier announces winners of 3rd Annual Scopus Young Indian Scientist Award 2Transporting juvenile salmon hinders adult migration 2Transporting juvenile salmon hinders adult migration 3Stowers Institute's Baumann Lab identifies key step in maturation pathway of telomerase 272 new members chosen by Academy 3096 172 new members chosen by Academy 3096 272 new members chosen by Academy 3096 372 new members chosen by Academy 3096 472 new members chosen by Academy 3096 572 new members chosen by Academy 3096 672 new members chosen by Academy 3096 772 new members chosen by Academy 3096 8Ohio Health Care Association Hosts Midwests Largest Long Term Care Convention in Columbus 17929 1Ohio Health Care Association Hosts Midwests Largest Long Term Care Convention in Columbus 17929 2Array BioPharma Selects SciQuest to Automate Procurement and Enable Agile Drug Development 4941 1Array BioPharma Selects SciQuest to Automate Procurement and Enable Agile Drug Development 4941 2Boost for green plastics from plants 3095 1Boost for green plastics from plants 3095 2
..., globalization is threatening the time-honored tr...eneration, with adverse effects on childhood healt... this week in the Proceedings of the National Acad...and especially mothers, who know more about plants...ependent of other factors such as education, marke...
...nogen, found in circulating blood and important in...S) when it leaks from the blood into the brain, tr...ve damage. Researchers at the University of Califo...ntified a fibrin-derived peptide that inhibits thi... MS, reducing MS symptoms. , "Current strategies ...
...n called TCTP (translationally controlled tumor pr...ey are smaller than normal, indicating that the pr...ration of cells, said researchers at Baylor Colleg...journal Nature. , Work in his laboratory shows th...ogue enriched in brain), a protein controlling gro...
...c areas in sound processing centers in the brains ...en the animals watch a video. , This study confirm...sical thinking, in which hearing, taste, touch, si...s of the brain and only later integrated. The new ... Planck Institute for Biological Cybernetics in Tü...
Other Biology News:Mother knows best: Plant knowledge key to childhood health in remote Amazon 2Inhibiting blood to save the brain 2Do you hear what i see? 2
(Date:12/4/2008)...ll/ -- Cell Therapeutics, Inc. ("CTI",or the "Com... a single,institutional investor shall purchase, ...Senior Notes due 2011 (the "Notes"), with a conver...Notes would have a $32.65 million initial principa...tling the holder, upon any conversion of,the Note...
(Date:12/4/2008)...onstruction of Synthetic Genomes , , ROCKV...rchers at the J. Craig Venter Institute (JCVI), a ... published a paper describing a significant advanc...emble the whole bacterial genome, Mycoplasma geni...d author Daniel G. Gibson, Ph.D. and his team publ...
(Date:12/4/2008)...h of potential vaccine for low-resource countries ... The biotech company Lentigen Corpo...n PATH announced today a partnership to accelerate...ll initially invest $3 million over 27 months and ... H5N1 virus-like particle (VLP) prototype pandemic...
(Date:12/4/2008)...all/ -- NeoStem, Inc.,(NYSE Alternext US: NBS), w...ocessing and long-term storage of adult stem cells... has reached a major milestone in its current busi...ection center for collection of,adult stem cells ...ew York,City and has chosen Bruce Yaffe, M.D., Ya...
Breaking Biology Technology:Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes 3J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 2J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 3J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 4J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 5Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 2Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 4
...Washington - The National Committee for Quality ...Centricity Physician Office system as the first el...port doctors who wish to pursue the NCQA/ American...ion Program (DPRP). , ,To qualify for DPRP recogn...mple of their patient files and calculate the perc...
... Can you summarize your corporations story in a f...ty with customers, key stakeholders, and the gener...ebank International, 5,000 major corporations arou...ed to measure the impact of their image on custome...There was also a strong emphasis on cyber-branding...
...Madison, Wis. - GenTel BioSurfaces, Inc. , a pri...ith Taiwan-based Abnova Corp. , the world,s large...nova,s protein and antibody content manufacturing ...munoassay development service. , ,GenTel,s flagshi...will be used to develop new custom multiplex immun...
... Last week, I traveled to Israel as part of an Ill... of entry into the U.S. market to Israeli companie...Science sector among multiple sectors of Illinois ...d in experiencing firsthand the Israeli Life Scien...year. During my stay in Israel, I met with many of...
Other Biology Technology:Does your company have an identity crisis? 2Does your company have an identity crisis? 3The Israeli life science juggernaut 2The Israeli life science juggernaut 3The Israeli life science juggernaut 4
Glucagon-like peptide-1 (GLP-1 (1-36) amide)
...ocalization in Early Drug Development with Imaging... localization data in early drug development using...s spectrometry service maps unlabeled ions and a...alize drugs and metabolites prior to synthesizing ...
Best pricing for 100mg-1.0g scales. Phosphopeptides are our specialty.
...F 2D is an automated, two-dimensional fractionatio...rotein mixtures. Part of Beckman Coulters Proteom...s in just hours. The system effectively resolves ... addressing a key challenge in todays proteomics r...
Biology Products: